Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHUR.L Share News (HUR)

  • There is currently no data for HUR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: Future Rises After Positive Annual Outlook

Mon, 01st Jul 2019 10:49

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------DS Smith, up 1.7%. The paper and packaging firm said it completed the sale of two packaging businesses in north west France and in Portugal to Memphis, Tennessee-based peer International Paper for EUR63 million. DS Smith said the sale honours the commitment made to the European Commission in relation to the clearance of its acquisition of Spanish packaging firm Europac, which completed in January. Last month, DS Smith had said financial 2019, which ended on April 30, was a "year of good delivery" overall, with "substantial" progress being made overseas and the integration of Europac was going well. Fellow packaging firms Smurfit Kappa and Mondi were up 2.6% and 1.7%, respectively. ----------FTSE 100 - LOSERS----------Fresnillo, down 2.9%. The Mexican gold miner was tracking spot gold prices lower, quoted at USD1,390.28 an ounce, down sharply from USD1,411.62 late Friday. Last week, gold had touched a six-year high of USD1,438.63. Additionally, Fresnillo on Monday said it has decided to align tax treatment for all of the company's underground mining operations, resulting in a USD8.0 million impact on profit for the six months to June-end. Shares in midcap gold miners Centamin and Hochschild Mining also were being hurt by the lower gold price, down 2.2% and 1.7%, respectively.----------International Consolidated Airlines Group, down 1.2%. Bernstein downgraded the airlines operator to Market Perform from Outperform. ----------FTSE 250 - WINNERS----------Future, up 9.0%. The digital media and publishing firm said full-year results will be ahead of expectations, underpinned by good audience growth within the Media division and the continued strong performance of recent acquisitions. The guidance was also attributed to a continuation of positive trends seen in the first half. Future's financial year ends September and will report annual results in November. "Future has a platform which enables it to monetise specialist content through a mixture of e-commerce, getting content users to click through to partnered retailers, events and online advertising. The plan is to feed newly-acquired assets into this platform. Newspaper and magazine publishers continue to battle falling sales and have struggled to get readers to pay for their relatively generic content, but consumers have shown a greater willingness to pay for specialist and niche content which they are unable to get elsewhere," said AJ Bell's Russ Mould.----------FTSE 250 - LOSERS----------John Laing Group, down 1.0%. Barclays started coverage on the infrastructure project investor at Equal Weight. ----------OTHER MAIN MARKET AND AIM - WINNERS----------Tiziana Life Sciences, up 14%. The biotechnology company noted a study in which a drug similar to Foralumab was shown to delay the onset of type-1 diabetes. The phase two study of Teplizumab, an anti-CD3 antibody similar to Foralumab being developed by Provention Bio, was published in the New England Journal of Medicine. Type-1 diabetes is caused by the immune system's T cells attacking insulin-producing cells in the body. Anti-CD3 antibodies like Tiziana's Foralumab and Provention Bio's Teplizumab suppress the immune system to prevent this from happening. Teplizumab is derived from mice and was injected intravenously in patients whose relatives already have type 1 diabetes. Of the 76 patients evaluated, 72% were under 18. The patients were randomised to receive either a 14-day course of Teplizumab or placebo and tested at six-month intervals. At the end of the Teplizumab trial, 57% of participants treated with the drug had not developed diabetes compared to 28% on the placebo.----------OTHER MAIN MARKET AND AIM - LOSERS----------Hurricane Energy, down 17%. The oil and gas explorer said it will abandon and plug the Warwick Deep well after it did not produce at commercial rates. Hurricane had drilled the offshore North Sea well to 1,964 metres, with results indicating a 712-metre horizontal section of fractured basement reservoir. However, initial analysis suggests the well found a "poorly" connected part of the fracture network within the oil column, and the well produced at non-commercial rates. Following plugging and abandoning Warwick Deep, Hurricane will move the rig to the Lincoln Crestal wall, the second of three wells on the Greater Warwick Area.----------

More News
17 Jan 2022 10:49

Hurricane Energy annual revenue rises on higher average oil price

Hurricane Energy annual revenue rises on higher average oil price

Read more
20 Dec 2021 11:41

AIM WINNERS & LOSERS: Fundraise lifts ImmuPharma; Proteome wins deal

AIM WINNERS & LOSERS: Fundraise lifts ImmuPharma; Proteome wins deal

Read more
20 Dec 2021 10:14

Hurricane Energy shares drop after review into failed debt restructure

Hurricane Energy shares drop after review into failed debt restructure

Read more
16 Dec 2021 17:22

TRADING UPDATES: Confident outlooks from Hunting, Audioboom, SigmaRoc

TRADING UPDATES: Confident outlooks from Hunting, Audioboom, SigmaRoc

Read more
15 Dec 2021 14:11

Hurricane Energy completes convertible bond repurchase

Hurricane Energy completes convertible bond repurchase

Read more
10 Dec 2021 10:11

Hurricane Energy buys back convertible bonds due 2022 to reduce debt

Hurricane Energy buys back convertible bonds due 2022 to reduce debt

Read more
8 Dec 2021 22:09

TRADING UPDATES: Beximco gets more Covid doses; AdEPT wins contract

TRADING UPDATES: Beximco gets more Covid doses; AdEPT wins contract

Read more
16 Nov 2021 11:25

Hurricane Energy's Lancaster field exceeds expectations in October

Hurricane Energy's Lancaster field exceeds expectations in October

Read more
14 Oct 2021 11:49

Hurricane Energy swings to profit and sets sights on bond repayment

Hurricane Energy swings to profit and sets sights on bond repayment

Read more
14 Oct 2021 10:49

AIM WINNERS & LOSERS: Hurricane Energy shares rise on swing to profit

AIM WINNERS & LOSERS: Hurricane Energy shares rise on swing to profit

Read more
7 Oct 2021 16:04

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
29 Sep 2021 11:50

AIM WINNERS & LOSERS: Nostra Terra jumps on reserves upgrade

AIM WINNERS & LOSERS: Nostra Terra jumps on reserves upgrade

Read more
29 Sep 2021 10:52

Hurricane expects output at guidance top end, warns of disruption risk

Hurricane expects output at guidance top end, warns of disruption risk

Read more
20 Sep 2021 08:48

CORRECT: Hurricane Energy output meets pre-shutdown level at Lancaster

CORRECT: Hurricane Energy output meets pre-shutdown level at Lancaster

Read more
17 Sep 2021 10:54

Hurricane Energy output returns to pre-shudown level at Lancaster well

Hurricane Energy output returns to pre-shudown level at Lancaster well

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.